Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,175,577 | $6,571,055 | $9,392,076 | $12,120,840 |
| - Cash | $1,188,082 | $674,253 | $648,512 | $891,451 |
| + Debt | $1,472,094 | $1,179,199 | $1,179,322 | $858,740 |
| Enterprise Value | $13,459,589 | $7,076,001 | $9,922,886 | $12,088,129 |
| Revenue | $5,719,742 | $4,122,506 | $3,605,047 | $5,224,712 |
| % Growth | 38.7% | 14.4% | -31% | – |
| Gross Profit | $2,181,553 | $1,524,347 | $1,462,063 | $2,804,065 |
| % Margin | 38.1% | 37% | 40.6% | 53.7% |
| EBITDA | $2,092,967 | $1,280,282 | $1,293,667 | $2,568,968 |
| % Margin | 36.6% | 31.1% | 35.9% | 49.2% |
| Net Income | $1,077,434 | $510,304 | $541,110 | $1,412,609 |
| % Margin | 18.8% | 12.4% | 15% | 27% |
| EPS Diluted | 1.82 | 0.85 | 0.9 | 2.35 |
| % Growth | 114.1% | -5.6% | -61.7% | – |
| Operating Cash Flow | $1,568,602 | $543,663 | $208,729 | $2,269,845 |
| Capital Expenditures | -$224,597 | -$325,929 | -$308,838 | -$263,739 |
| Free Cash Flow | $1,344,005 | $217,734 | -$100,109 | $2,006,106 |